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Abstract 14 
Photodynamic therapy (PDT) offers potential as a non-invasive treatment of periodontal 15 
disease. In this study, microcosm biofilms were grown in vitro under conditions designed 16 
to mimic subgingival plaques typically found in patients with periodontitis. To 17 
investigate potential PDT modalities, biofilms were exposed to light from a helium/neon 18 
laser in conjunction with a photosensitiser, toluidine blue (TBO), at varying output and 19 
concentration, respectively. To determine cytotoxic effects, viability profiling was 20 
undertaken on whole biofilms using standard plating methods, and on horizontal cross-21 
sections of biofilms using confocal laser-scanning microscopy (CLSM) in conjunction 22 
with a differential viability stain. A light energy dose of 94.5 J in combination with 81.7 23 
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M TBO was found to be optimal, achieving significant kills of over 97%. CLSM 24 
enabled visualisation of the effects of PDT in three dimensions. Viability profiling of the 25 
CLSM images revealed that lethal photosensitisation was most effective in the upper 26 
layers of biofilm. PDT was found to reduce the viability of subgingivally-modelled 27 
plaques in vitro by a similar magnitude to chlorhexidine digluconate (CHL), which is 28 
commonly used to treat periodontal disease. The findings of this study indicate that PDT 29 
may be an effective alternative to conventional modalities in the treatment of periodontal 30 
disease. 31 
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Introduction 36 
Periodontal disease is caused by the accumulation of subgingival plaque biofilm 37 
near the gingival margin and is responsible for up to 60% of tooth loss in the UK.  38 
Chronic marginal gingivitis probably affects the whole dentate population at some stage 39 
and is characterised by inflammation of the gum margin.  If the build-up of gum marginal 40 
plaque is left unchecked, gingivitis can develop into the more serious condition of 41 
chronic adult periodontitis (Pihlstrom et al 2005).  This condition is characterised by the 42 
migration of the junctional epithelium tissue at the base of the gingival crevice down the 43 
tooth to form a periodontal pocket.  The cause of this pocketing has been attributed to 44 
tissue destruction as a consequence of bacterial stimulation of host degradative enzyme 45 
production (e.g. matrix metalloproteinases) and invasion of host cells (Bodet et al 2007, 46 
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Amano, 2003).  The (probing) depth of the periodontal pocket is used as an indicator of 47 
the spread of the disease and The Adult Dental Health Survey (1998) revealed that 54% 48 
of the UK adult dentate population had probing depths greater than 3.5 mm (moderate 49 
periodontal disease) whilst 8% of the population had a loss of attachment over 5.5 mm 50 
(severe destructive periodontitis) (Morris et al 2001).  The annual cost of NHS 51 
periodontal therapy in 2001/2002 was £174 million on 15.5 million treatment episodes 52 
(Chapple, 2004).  Conventional periodontal therapy routinely involves root scaling / 53 
planing which may be complemented with adjunct antimicrobial chemotherapy, such as 54 
doxycycline (Tuter et al 2007). 55 
Bacteria harboured within biofilms are notoriously recalcitrant to antimicrobial 56 
agents (Costerton et al 2003, Anwar et al 1990, Millward & Wilson, 1989) and their 57 
eradication represents a formidable challenge where they are associated with disease.  58 
The mechanisms by which biofilms resist conventional antimicrobial agents are generally 59 
considered to be multifactorial, although current understanding is that the production of 60 
high numbers of essentially invulnerable persister cells, in response to shock proteins or 61 
‘alarmones’, is the most significant of these factors (Gilbert et al 2002b). 62 
 Treatment of bacterial infections by PDT offers an alternative to the use of 63 
antimicrobial agents (Malik et al 1990) and to invasive dental procedures which are 64 
associated with patient trauma. The bactericidal effect associated with PDT (known as 65 
lethal photosensitisation) is caused by the generation of cytotoxic free radicals, such as 66 
singlet oxygen, when a photo-reactive agent (photosensitiser) is excited by light of an 67 
appropriate wavelength (Malik et al 1990).  PDT has been used clinically to treat a 68 
number of systemic conditions including tumor (Choi et al 2006). Interest in its 69 
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application to treat bacterial infections is gaining momentum – the treatment of 70 
periodontal disease being one of the most promising (Meisel & Kocher, 2005).  A major 71 
benefit of PDT is that the bactericidal effect is localised to areas which are treated with 72 
both photosensitiser and light, preventing disruption of the indigenous microflora at sites 73 
distal to the treated area (Wilson, 2004).  The non-specific mode of action of PDT, 74 
expressly the generation of singlet oxygen, means that the acquisition of bacterial 75 
resistance to these agents is unlikely. 76 
Previous studies have examined the effects of PDT on single-species biofilms 77 
using streptococci to model supragingival plaque in conditions associated with onset of 78 
dental caries (Zanin et al 2005, Zanin et al 2006) and Streptococcus pyogenes to model a 79 
skin biofilm (Hope & Wilson, 2006).  However, PDT also offers a promising, non-80 
invasive treatment for periodontal disease. Previously, it was reported that toluidine blue 81 
and helium/neon laser light could kill significant numbers of bacteria associated with 82 
periodontal disease, using a simple system where bacteria were grown on nitrocellulose 83 
membranes (O’Neill et al 2002). In this investigation we describe the modelling of 84 
subgingival plaque using a sophisticated in vitro model more representative of in vivo 85 
conditions. 86 
The aim of this study therefore was to investigate the susceptibility of microcosm 87 
subgingival periodontal plaques grown in a constant-depth film fermenter (CDFF) to 88 
PDT using a range of biofilm viability profiling techniques, and to compare the 89 
effectiveness of PDT to the commonly used oral antimicrobial, CHL, representative of a 90 
conventional, non-invasive modality. 91 
 92 
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Materials and Methods 93 
Subgingival plaque inoculum 94 
Subgingival plaque samples were obtained from ten patients attending the 95 
Eastman Dental Hospital, London, for treatment of moderate-to-advanced adult 96 
periodontitis.  Each sample consisted of the contents of at least two periodontal pockets 97 
from each patient.  The samples were pooled and mixed in pre-reduced BHI broth 98 
(Oxoid, Basingstoke, UK) containing 10% glycerol and then aliquoted into 1 ml volumes 99 
and stored at -70ºC, to generate a bank of homogenous innocula for use throughout this 100 
series of experiments.  Two vials of homogenised plaques were used as the inoculum to 101 
produce the biofilms in vitro.  Compositional studies (using culture and molecular 102 
methods) on biofilms produced from this pooled inoculum using the method described 103 
below, demonstrated the presence of many of the genera found in subgingival plaque 104 
including; Veillonella, Streptococcus, Proprionibacterium, Eubacterium, Micrococcus, 105 
Actinomyces, Fusobacterium and Porphyromonas (O’Neill, unpub. Ph.D thesis, Univ. 106 
London, 2006), the latter three genera being especially associated with periodontal 107 
disease. 108 
 109 
Production of microcosm subgingival dental plaques 110 
Operation of a constant-depth film fermenter (CDFF) (University of Wales, 111 
Cardiff, UK) to produce multi-species oral biofilms modelling those associated with 112 
periodontal disease has previously been described (Allan et al 2002, Hope & Wilson 113 
2006). In this study, to model the microaerophillic conditions found in periodontal 114 
pockets (Mettraux et al 1984), the CDFF was operated by continuous flushing (60 cm
3 
115 
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min
-1
) with a gas mixture consisting of 95% N2, 3% CO2, 2% O2. The growth medium 116 
used to enable propagation of biofilms from the microcosm plaques consisted of RPMI 117 
(60%) (Sigma, Poole, UK) / horse serum (40%) (Oxoid) supplemented with 0.5 g ml
-1
 118 
menadione and 5.0 g ml
-1
 hemin.  The CDFF was housed within an incubator at 37ºC. 119 
The substratum for subgingival plaque is enamel/cementum, the mineral component of 120 
which is similar to hydroxyapatite (HA). HA discs were therefore used as the substratum 121 
for biofilm formation. The CDFF housed fifteen sample pans on a rotating turntable, each 122 
pan containing five HA discs, of 5 mm diameter. Discs were recessed to a depth of 100 123 
m. 124 
The inoculum was added to 500 ml growth medium and pumped onto the rotating 125 
HA substrata for 8 h, at a rate of 1 ml min
-1
. The CDFF was then connected to fresh 126 
medium which was supplied at the same flow rate and biofilms were then grown for 7 127 
days before being removed for experimentation. 128 
 129 
Photosenitisation and laser application 130 
TBO (Sigma) was used at concentrations of 32.7, 65.4, 81.7 or 163.4 M in 0.85% 131 
saline. The laser used was a Helium/Neon (He/Ne) gas laser (Spectra-Physics, Darmstadt-132 
Kranichstein, Germany) with a measured power output of 35 mW. Light was emitted in a 133 
collimated beam of 3.5 mm diameter, with wavelength of 632.8 nm.  To irradiate biofilms, 134 
laser light was passed through a lens (x2 magnification), allowing light coverage of the 135 
entire biofilm surface. 136 
To test biofilm susceptibility to TBO/HeNe laser light, pans were removed and 137 
the biofilm-containing discs removed and placed in microtitre plate wells.  10 l of TBO 138 
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was added to each biofilm for sensitisation. Laser light intensities of 63 J (163.8 J cm
-2
) 139 
and 95.4 J (248 J cm
-2
) were employed (L+S+). Controls were TBO in the absence of 140 
laser light (L-, S+), and addition of 10 l sterile saline, with or without laser light (L+S- 141 
and L-S-, respectively). In addition to controlling for laser light and TBO exposure, L-S- 142 
also served to determine whether exposure to an aerobic atmosphere for the duration of 143 
the experiment had any effect on bacterial viability.  A pre-exposure time of 5 minutes (in 144 
the absence of light) was applied to allow the solutions to penetrate into the biofilm. The 145 
L+S+ and L+S- samples were then exposed to laser light for 15 min.  Discs were then 146 
immersed in 1 ml pre-reduced BHI broth and biofilms re-suspended by vortexing for 60 147 
sec. The total number of viable, culturable bacteria (CFU ml
-1
) from re-suspended 148 
biofilms before and after treatment was determined by viable counting on Fastidious 149 
Anaerobe Agar (FAA) (Bioconnections, Leeds, UK) containing 5 % (v/v) defibrinated 150 
horse blood (E & O Laboratories, Bonnybridge, UK). Duplicate 25 l aliquots were 151 
spread over the surface of FAA plates and these incubated for 7 days at 37ºC in an 152 
anaerobic atmosphere, and resultant colonies counted. 153 
 154 
CLSM of biofilms subjected to PDT 155 
Biofilms were subjected to either PDT using 63 J HeNe laser light and 81.7 M 156 
TBO, or no treatment as described above. Post-PDT biofilms were then placed into a 157 
miniature Petri dish, biofilm uppermost and stained using the BacLight  bacterial 158 
viability kit (Molecular Probes, Oregon, USA) with 5 min stain penetration time in 159 
darkness.  Scans were taken of the biofilms using a Leica DMLFS fixed stage microscope 160 
with a Leica TCS SP confocal scan-head.  The objective lens was a 63x HCX water 161 
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immersion dipping lens. Confocal image stacks were captured of both the viable (488nm) 162 
and non-viable (568nm) fluorescent emissions. Data are from two biofilms, one an 163 
untreated control (L-S-), and the other subjected to PDT (L+S+).   164 
 165 
Analysis of CLSM data 166 
Fluorescence intensity profiles (Hope et al 2002) through the biofilms were 167 
generated by measuring the brightness of each optical section in the confocal image 168 
stack, for both the viable (488 nm) and non-viable (568 nm) channels, using ImageJ 169 
computer software (ImageJ 1.36d, The National Institutes of Health, USA, 170 
http://rsb.info.nih.gov/ij/).  To enable an effective comparison between the viable and 171 
non-viable channels, these data were normalised against the maximum image intensity 172 
for each individual channel (maximum value = 1) and plotted against depth into the 173 
biofilm.  Zero-depth was taken as the top of the confocal image stack. 174 
Projection images were constructed by combining all confocal optical sections 175 
into one image. 176 
 177 
Susceptibility of biofilms to chlorhexidine digluconate 178 
Two pans, each containing five biofilms, were removed aseptically from the 179 
CDFF and placed in a sterile glass container. To this was added 5 ml 0.2% CHL (Sigma) 180 
or, in the case of the control pan, 5 ml PBS (Oxoid, Basingstoke, UK) and incubated for 1 181 
or 15 min. Biofilms were then prepared for viable counting as described above. In 182 
parallel, PDT was applied to biofilms of the same age using a regime of 2.1 J HeNe laser 183 
light with 81.7 µM TBO for 1 min and then prepared for viable counting. In addition, the 184 
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15 min CHL exposure results were compared to the data generated using the PDT 185 
modalities described above (15 min treatment).  186 
 187 
Statistical analyses 188 
The statistical significance of the data was ascertained using the two-tail t-test 189 
assuming unequal variance. For viable counting following PDT, four individual biofilms 190 
were used to determine CFU ml
-1
 by plating in duplicate, n=8.   For CHL and TBO 191 
studies, three biofilms were plated in duplicate, n=6. For ease of interpretation, viability 192 
is recorded as percentage kill compared to untreated control. 193 
 194 
Results 195 
Effect of PDT on biofilm viability 196 
Table 1 shows the effect of increasing light dose and photosensitiser concentration on the 197 
efficacy of lethal photosensitisation in terms of the percentage of bacteria killed. The 198 
most effective combination of light and photosensitiser was 94.5 J and 81.7 M TBO, 199 
which produced a significant kill of 97.4%. A reduced TBO concentration of 65.4 M 200 
with the same light dosage still produced a significant kill of 95.0%.  Increasing 201 
photosensitiser concentration to 163.4 M but still using 94.5 J laser light reduced the 202 
efficacy of the procedure, producing a diminished, but significant, kill of 74.4%. A 203 
photosensitiser concentration of 32.7 M in combination with a light dose of 94.5 J was 204 
sufficient to produce a significant bactericidal effect, with a kill of 82.7%. 205 
Reducing the light dosage from 94.5 to 63 J reduced the bactericidal efficacy of 206 
PDT. 63 J laser light with a photosensitiser concentration of 81.7 M produced a 207 
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significant kill of 69.0%, however this kill was less than that observed at the higher light 208 
dosage using the same photosensitiser concentration, albeit the difference was not 209 
significant. 63 J of laser light in conjunction with 32.7 M TBO was insufficient to 210 
produce a significant lethal effect. 211 
 212 
CLSM studies on biofilms subjected to PDT 213 
Microcolony formations interspersed with water channels can be seen in the 214 
control biofilm shown in figure 1a. Viable cells (green) appeared to be far more 215 
numerous than the non-viable cells (blue). (It should be noted that the red, non-viable 216 
stain used in the procedure was digitally altered to appear blue using ImageJ for ease of 217 
interpretation).  Figure 1b shows a multi-species biofilm that was subjected to lethal 218 
photosensitisation with 63 J of HeNe laser light in the presence of 10 l of 81.7 M TBO.  219 
Visually, there was a discernible difference between this biofilm and the control (figure 220 
1a). The structure of the biofilm seems to have been disrupted by exposure to the light in 221 
the presence of the TBO. In addition, there appeared to be a larger proportion of non-222 
viable to viable cells compared to the control biofilm. 223 
The normalised fluorescence image intensity profile through the control biofilm 224 
(figure 2) conformed to those observed previously (Hope et al 2002, Hope & Wilson, 225 
2006) in similar supragingival and subgingival plaque biofilm models.  Biofilm which 226 
was exposed to 63 J of HeNe laser light in the presence of TBO (figure 3) showed a 227 
broader distribution of non-viable fluorescence, particularly in the upper layers closest to 228 
the illumination source. 229 
 230 
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Effect of chlorhexidine digluconate on biofilm viability 231 
Exposure of biofilms to 0.2% CHL for 1 min did not result in a statistically 232 
significant reduction in the number of recovered viable organisms post-exposure when 233 
compared to the control, whereas exposure for 15 min with this treatment resulted in a 234 
significant reduction of 99.7%. 1 min exposure to PDT using a combination of 2.1 J of 235 
laser light and 81.7 µM TBO did not produce a significant kill, whereas (as described 236 
above) combinations of 63 J (163.8 J cm
-2
) with 81.7 µM TBO and 94.5 J (248 J cm
-2
) 237 
with 32.7, 65.4, 81.7 and 163.4 µM TBO produced significant reductions in biofilm 238 
viability. 239 
240 
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Discussion 241 
PDT was performed using two light doses, 63 J (163.8 J cm
-2
) and 95.4 J (248 J 242 
cm
-2
), with a range of photosensitiser concentration, the latter light dosage proving the 243 
most effective.  244 
Inconsistencies in effect of laser and photosensitiser activity alone on biofilm 245 
viability were observed. In all but one instance, these were not significant. However, 94.5 246 
J laser light, and 81.7 M TBO alone, produced significant kills (54.4% and 57.1% 247 
respectively), although these kills were much lower than those achieve in combination 248 
(97.4%). It is possible that the variability encountered in these experiments was due to the 249 
heterogeneous nature of these multispecies biofilms, where perhaps unculturable bacteria 250 
accounted for varying proportions of biofilm biomass. Alternatively, the treatments alone 251 
may have contributed a small antimicrobial effect. Further experiments, with larger 252 
sample sizes are required to build on this preliminary study.  253 
A combination of 63 J laser light and 81.7 M TBO produced the greatest 254 
bactericidal effect, as determined by viability studies using plate culture. An increase in 255 
the photosensitiser concentration (to 163 M) did not effect an increase in bactericidal 256 
activity of PDT. This observation seems counter-intuitive; one would have envisioned 257 
that increasing the concentration of photosensitiser applied to the biofilm would result in 258 
an increase in kill. However, if the TBO solution was too concentrated, penetration of the 259 
solution by the laser light would be impeded. Thus, a shielding effect (Herzog et al 1994) 260 
could occur, preventing the excitation of TBO proximal to the biofilm bacteria, with a 261 
consequent reduction in efficacy of killing.  Alternatively, TBO may also aggregate at 262 
higher concentrations localising its presence and preventing adequate pervasion of the 263 
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target material. This may also account for the lack of increased efficacy at higher 264 
concentrations (Sternberg & Dolphin, 1996). If the concentration of TBO used is sub-265 
optimal for the light dose administered, photo-bleaching will occur (Rigaut & Vassy, 266 
1991) resulting in degradation of photosensitiser, and diminished bactericidal activity. 267 
Thus, there appears likely to be a concentration of TBO optimal for photosensitisation – 268 
sufficient to prevent bleaching but below a threshold where its presence becomes 269 
detrimental to the procedure. 270 
CLSM studies utilised the BacLight™ bacterial viability kit (LIVE/DEAD) to 271 
determine the viability profile of bacteria within the biofilms and revealed biofilms of 272 
typical architecture, similar to those observed in other CLSM studies e.g. Costerton et al 273 
(1994), Hope et al (2002). Microcolonies interspersed with water channels were visible 274 
(figure 1a).  275 
Analyses of the control biofilms (L-S-) (figure 2) revealed that in general there 276 
was little difference in the spatial distribution of live cells relative to dead cells, with the 277 
exception that at the margins of the upper and, in particular, lower biofilm interfaces 278 
there seemed to be a slight increase in dead cells. In the case of the upper surface it is 279 
possible that obligately anaerobic bacteria were killed during the sampling process (Hope 280 
& Wilson, 2006). At the biofilm/substratum interface there may have been nutrient 281 
limitation or a build up of toxic products (especially in areas relatively distant from water 282 
channels) that may have resulted in the death of some cells.  283 
Biofilms exposed to laser light and photosensitiser showed evidence of lethal 284 
photosensitisation, as indicated by an increasing proportion  of dead cells, particularly in 285 
the upper portion of the biofilm (0 to 10 µm), suggesting that PDT was most effective in 286 
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this area (figure 3). In addition to the possible limitations associated with photosensitiser 287 
efficacy discussed above, it is also possible that with increasing depth, biofilms became 288 
increasingly more resistant to PDT. This may be due to reduced growth rate of cells with 289 
increasing depth in the biofilm, a known contributor to antimicrobial resistance in biofilm 290 
populations (Evans et al 1990, Roberts & Stewart, 2004). 291 
CHL is used in the treatment of a wide range of oral infections, including 292 
periodontitis (Pietruska et al 2006). Its efficacy against subgingivally-modelled in vitro 293 
biofilms was compared to that of PDT to provide an indication of the suitability of PDT 294 
as a putative therapeutic regime in treating periodontal disease.  CHL (at 0.2%) did not 295 
produce a significant kill when applied to the biofilms for 1 min, suggesting that this may 296 
be an ineffective treatment when directed against periodontal plaques of similar 297 
dimensions in situ. CHL did produce a statistically significant kill after 15 min, although 298 
this would be an impractical exposure period clinically. However, it is possible that a 299 
similar kill could have been achieved with an exposure period somewhere between 1 and 300 
15 min or at increased concentration (not tested). When PDT was employed with a low 301 
light dosage (2.1 J) for 1 min, no significant reduction in viability of the biofilms was 302 
observed. However, as discussed above, comprehensive, significant kills were achieved 303 
with 15 min exposure at increased light intensities, and optimally with a light dose and 304 
photosensitiser concentration of 94.5 J and 81.7 M, respectively. Hence, from these 305 
preliminary in vitro data one can conclude that PDT (using toluidine blue and HeNe laser 306 
light) can be as effective as CHL when directed against biofilms similar to those found in 307 
periodontal disease. 308 
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The site-specific clinical application of PDT would enable avoidance of the use of 309 
antibiotics (which are often used following periodontal surgery) and the associated 310 
problem of perturbation of the indigenous systemic microflora e.g. gastrointestinal upset. 311 
The increasing prevalence of bacterial antibiotic resistance necessitates the development 312 
of alternative antibacterial therapies. Sublethal concentrations of biocides may also select 313 
for mutants expressing multidrug efflux pumps which can also render them antibiotic 314 
resistant (Gilbert et al 2002a). Thus, routine use of antimicrobial oral healthcare products 315 
could conceivably select for a population of bacteria with an intrinsic ability to resist 316 
antibiotic therapy, and consequently limit the effectiveness of antibiotic treatment 317 
following periodontal surgery. Development of resistance to chlorhexidine has been 318 
demonstrated in some Gram-negative bacteria including Psuedomonas aeruginosa 319 
(Thomas et al 2000) and Klebsiella pneumoniae (Fang et al 2002). With PDT, lethal 320 
photosensitisation mediates bacterial killing via singlet oxygen and free radicals.  Thus, 321 
resistance development would be unlikely due to the multiplicity of target sites which 322 
include the outer and plasma membranes of Gram-negative bacteria, DNA, and 323 
photolabile surface-associated proteins (Bhatti et al 1998, Bhatti et al 2001) against which 324 
the generated singlet oxygen and free radicals are active. 325 
 326 
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Table 1. Effect of laser light intensity and sensitiser concentration on kill efficacy.  453 
Light intensity (J) TBO concentration ( M) % kill 
63  32.7 41.9* 
63 0 0* 
0 32.7 72.6* 
63 81.7 69.0 
63 0 0* 
0 81.7 36.3* 
94.5 32.7 82.7 
94.5 0 0* 
0 32.7 0* 
94.5 65.4 95.0 
94.5 0 0* 
0 65.4 0* 
94.5 81.7 97.4 
94.5 0 54.4 
0 81.7 57.1 
94.5 163.4 74.4 
94.5 0 0* 
0 163.4 0* 
* not significant 454 
 455 
456 
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 457 
Figure 1a: Projection of confocal image stack of a control CDFF-cultivated multi-species 458 
biofilm (L-S-). Bar represents 20 µm. Viable cells = green, non-viable cells = blue. 459 
 460 
 461 
Figure 1b: Projection of confocal image stack of a CDFF-cultivated multi-species 462 
biofilm exposed to 63 J of HeNe laser light and 81.7 M TBO (L+S+).  Bar represents 20 463 
µm. Viable cells = green, non-viable cells = blue 464 
465 
 24 
 466 
Figure 2: Normalised fluorescence intensity profile of viable and non-viable stain as a 467 
function of depth in a control biofilm (L-S-), as determined by CLSM. 468 
 469 
 470 
Figure 3: Normalised fluorescence intensity profile of viable and non-viable stain in 471 
biofilms exposed to 63 J of HeNe laser light and 81.7µM pTBO (L+S+), as determined 472 
by CLSM. 473 
